NEW YORK (GenomeWeb) – Trovagene said after the close of the market on Tuesday that its revenues in the first quarter increased 14 percent year over year. 

For the three months ended March 31, the San Diego-based cell-free molecular diagnostics firm recorded $127,000 in total revenues, up from $111,000 in the year-ago quarter, easily beating analysts' average estimate of $80,000. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.